$VRTX Recent News Google, Amazon earnings on tap after

New Post Public Reply Private Reply Replies (0) Message Board

Feb 3, 2015 at 10:51 AM

$VRTX Recent News

Google, Amazon earnings on tap after hours 3:40 p.m. Jan. 29, 2015 - Sue Chang
Charting the S&P 500’s slow-motion breakout 11:00 a.m. Nov. 7, 2014 - Michael Ashbaugh
Twitter gives out 47% of its revenue in stock bonuses 12:51 p.m. Oct. 29, 2014 - Philip van Doorn
11 stocks rising the most as the market heads toward a correction 10:29 a.m. Oct. 15, 2014 - Philip van Doorn
Everything you need to know about investing you learned in grade school 2:09 p.m. Oct. 7, 2014 - Tomi Kilgore
S&P, Nasdaq violate major support 9:02 a.m. Oct. 1, 2014 - Michael Ashbaugh
Bed Bath, Starz gain; Citizens Financial debuts 2:52 p.m. Sept. 24, 2014 - Sue Chang
Oracle falls on earnings, Ellison move; Alibaba soars on debut 3:08 p.m. Sept. 19, 2014 - Sue Chang
Vertex Pharmaceuticals shares jump 4.9%, pace S&P 500 advancers 8:59 a.m. Sept. 5, 2014 - Tomi Kilgore
U.S. stocks push higher; biotechs rally 3:06 p.m. Aug. 13, 2014 - Anora Mahmudova
Vertex leads S&P 500, King drops on outlook 2:55 p.m. Aug. 13, 2014 - Sue Chang
10 stocks suffering the biggest cuts in earnings estimates 12:39 p.m. Aug. 11, 2014 - Philip van Doorn
Kinder Morgan soars, Tesla rallies on upgrade 11:46 a.m. Aug. 11, 2014 - Sue Chang
Mobileye rises for second day; Michael Kors falls 12:23 p.m. Aug. 4, 2014 - Sue Chang
Charting a slow-motion breakout attempt 10:08 a.m. July 23, 2014 - Michael Ashbaugh
U.S. stocks fall; Dow in triple-digit loss 3:36 p.m. June 24, 2014 - Anora Mahmudova
Dow falls over 100 points; energy stocks sell off: Stock market live blog recap 2:46 p.m. June 24, 2014 - blogs.marketwatch.com
Vertex soars on trial success; Best Buy gets buy rating 2:30 p.m. June 24, 2014 - Sue Chang
New studies bode well for Vertex's cystic fibrosis drug, analysts say 12:32 p.m. June 24, 2014 - Russ Britt
Vertex Pharmaceuticals shares skyrocket 50% 8:33 a.m. June 24, 2014 - Sue Chang

Vertex Should Expect Approvals For Its Cystic Fibrosis Medications 9:16 p.m. Feb. 2, 2015 - Seeking Alpha
Obama Announces Genetic-Mapping Plan 7:48 p.m. Jan. 30, 2015 - The Wall Street Journal Interactive Edition
Vertex Pharmaceuticals (VRTX) Downgraded From Hold to Sell 4:40 p.m. Jan. 30, 2015 - TheStreet.com
Is the 'January Effect' Signaling a Down Year for the Stock Market? 3:14 p.m. Jan. 30, 2015 - TheStreet.com
IBB Is +34% For 1 Year And +7.31% For 2015 - But What Are The Risks? 10:07 a.m. Jan. 30, 2015 - Seeking Alpha
Vertex Pharmaceuticals Slumps: VRTX Falls 5.9% in Session - Tale of the Tape 8:52 a.m. Jan. 30, 2015 - Zacks.com
Vertex Pharma Verging on Full Valuation 8:19 a.m. Jan. 30, 2015 - Barrons.com
Baird Releases Comments After Vertex Earnings Call 2:08 p.m. Jan. 29, 2015 - benzinga.com
Alexion Beats Q4 Estimates, Appoints New CEO 12:28 p.m. Jan. 29, 2015 - Investors Business Daily
Vertex Pharmaceutical (VRTX) Stock Declines Today Following Earnings Realease 11:44 a.m. Jan. 29, 2015 - TheStreet.com
Maxim Downgrades Vertex Pharmaceuticals After Earnings 11:00 a.m. Jan. 29, 2015 - benzinga.com
Vertex Posts Wider 4Q Loss, Affirms Kalydeco Outlook - Analyst Blog 10:10 a.m. Jan. 29, 2015 - Zacks.com
Vertex Phamraceuticals (VRTX) Earnings Report: Q4 2014 Conference Call Transcript 9:03 a.m. Jan. 29, 2015 - TheStreet.com
Continued Expansion Into The Cystic Fibrosis Treatment Market Bodes Well For Vertex 7:52 a.m. Jan. 29, 2015 - Seeking Alpha
Vertex Pharmaceuticals' (VRTX) CEO Jeffrey Leiden on Q4 2014 Results - Earnings Call Transcript 11:36 p.m. Jan. 28, 2015 - Seeking Alpha
Vertex Pharmaceuticals Incorporated (VRTX) Q4 2014 Results - Earnings Call Webcast 4:55 p.m. Jan. 28, 2015 - Seeking Alpha
Vertex Pharmaceuticals Beats Q4 Revenue Expectations 4:39 p.m. Jan. 28, 2015 - benzinga.com
Today's Post-Market Laggard Is Vertex Pharmaceuticals (VRTX) 4:30 p.m. Jan. 28, 2015 - TheStreet.com
Notable earnings after Wednesday's close 5:35 p.m. Jan. 27, 2015 - Seeking Alpha
Will Vertex (VRTX) Surprise with a Lower Loss in Q4? - Analyst Blog 11:20 a.m. Jan. 27, 2015 - Zacks.com

Technical Scrutiny on Biotech Stocks - Galena Biopharma, Synta Pharma, Merrimack Pharma, Vertex Pharma, and Spectrum Pharma 8:55 a.m. Jan. 7, 2015 - PR Newswire - PRF
Vertex Announces Upcoming Presentation at the J.P. Morgan Healthcare Conference and Date of Fourth Quarter and Full Year 2014 Financial Results 4:02 p.m. Jan. 6, 2015 - BusinessWire - BZX
On Winning Track: Complementary Research on Vertex, Ignyta, Novartis, Boeing and TransCanada 9:20 a.m. Dec. 30, 2014 - PR Newswire - PRF
U.S. Food and Drug Administration Approves KALYDECO® (ivacaftor) for Use in People with Cystic Fibrosis Ages 6 and Older Who Have the R117H Mutation 3:11 p.m. Dec. 29, 2014 - BusinessWire - BZX
David Altshuler, M.D., Ph.D., Joins Vertex as Executive Vice President of Global Research and Chief Scientific Officer 9:02 a.m. Dec. 15, 2014 - BusinessWire - BZX
MassMutual Announces the Election of Three Members to its Board of Directors 12:00 p.m. Dec. 10, 2014 - PR Newswire - PRF
Technical Scrutiny on Biotech Stocks - CTI BioPharma, Vertex Pharma, Progenics Pharma, iBio, and NewLink Genetics 8:45 a.m. Dec. 2, 2014 - PR Newswire - PRF
Vertex to Present at Deutsche Bank BioFEST on December 2 4:02 p.m. Nov. 20, 2014 - BusinessWire - BZX
Cystic Fibrosis Foundation Royalty Sale Will Be Transformational for People with CF 9:03 a.m. Nov. 19, 2014 - PR Newswire - PRF
Vertex Submits Applications in the U.S. and Europe for Approval of Lumacaftor in Combination with Ivacaftor for People with Cystic Fibrosis Who Have Two Copies of the F508del Mutation 7:03 a.m. Nov. 5, 2014 - BusinessWire - BZX
Vertex to Present at the Credit Suisse Healthcare Conference on November 11 3:04 p.m. Oct. 30, 2014 - BusinessWire - BZX
Arrival of Former FDA Senior Officials Accelerates Greenleaf Expansion 7:00 a.m. Oct. 29, 2014 - BusinessWire - BZX
Vertex Reports Third Quarter 2014 Financial Results 3:04 p.m. Oct. 28, 2014 - BusinessWire - BZX
Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 8:00 a.m. Oct. 24, 2014 - PR Newswire - PRF
FDA Advisory Committee Recommends Approval of KALYDECO® (ivacaftor) for Use in People with Cystic Fibrosis Ages 6 and Older Who Have the R117H Mutation 3:47 p.m. Oct. 21, 2014 - BusinessWire - BZX
Vertex to Announce Third Quarter 2014 Financial Results on October 28 3:01 p.m. Oct. 14, 2014 - BusinessWire - BZX
Vertex Reviews Recent Progress and Announces Upcoming Milestones in the Development of Multiple Combinations of Medicines that Target the Underlying Cause of Cystic Fibrosis 8:32 a.m. Oct. 9, 2014 - BusinessWire - BZX
Senior Housing Properties Trust Announces LEED® Gold Certification of the Vertex Pharmaceuticals Biotech Buildings 7:02 a.m. Oct. 8, 2014 - BusinessWire - BZX
Regulatory Approvals, Lawsuits, Positive Study Results, Welfare Initiatives, and Technical Updates - Research Reports on Celgene, Actavis, Bristol-Myers Squibb, UnitedHealth and Vertex 8:20 a.m. Oct. 2, 2014 - PR Newswire - PRF
Analyst Scanner on Biotech Equities - Prana Biotechnology, CytRx, Insmed, Dynavax Technologies, and Vertex Pharma 8:15 a.m. Sept. 11, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Syra Health Joins CMS ACCESS Model for Scalable Growth

Syra Health Secures Spot in CMS ACCESS Model Every once in a while, a company gets a nod that could redefine its trajectory, and today it’s Syra Health’s turn at bat. Teaming up with HealthSync, they’ve clinched a position in the coveted CMS ACCESS model—a move not just about snagging headlines but potentially securing a golden ticket to a robust revenue stream...

AWOL Vision's LuxVision: Pushing Home Cinema Limits

AWOL Vision Leaps into the Future at IFA 2026 You'll never look at home entertainment the same way. AWOL Vision's grand entrance at IFA 2026 in Berlin isn't just about a shiny new gadget; it's a full-blown mission to redefine what your living room can do. With its debut of the LuxVision projector, they're not just holding a torch—they're carrying a flamethrower into the...

Veteran Suicide Prevention: The Urgency Behind CVN's Push

Veteran suicide is a crisis staring us square in the face, with rates 60% higher than the general population. It's a grim reminder that the mental toll on those who've served is a deep chasm hard to bridge. Cohen Veterans Network (CVN) is stepping up to the plate with a new campaign dubbed 'Ask Anyway: Conversations to Save a Life'. This isn't just any awareness...

Baystate Noble Plans Major ED Expansion for Future Needs

A Trusted Name in Healthcare Steps Up When a healthcare player like Baystate Health decides to jump into the deep end with an expansion project, you know they're not just doodling on napkins. With a legacy stretching back to 1883, Baystate Health, anchored deeply in western New England, isn't just expanding for fun—it's a move to cement its position as a crucial...

TPx Pivots Post-Bankruptcy, Rebuilding for New Growth

TPx Rebounds with Stronger Foundation Folks, TPx just got itself a fresh pair of legs to stand on. Emerging from the labyrinth of Chapter 11 bankruptcy, TPx has managed to shave off a cumbersome load of debt and cement a pathway to long-term success. A court nod from the U.S. Bankruptcy Court for the Southern District of Texas confirmed their reorganization plan. It's a...

Mitrade EU Enhances Investor Safety with New Insurance

Mitrade's New Insurance: A Safety Net? Mitrade EU is amping up its game with some fresh insurance perks that catch the eye. They're slapping on some extra insolvency protection for clients trading under their CySEC license. Now that sounds like a financial shield anyone would want. Basically, they're adding another layer to the basic regulatory protections, and without...

Finzly Launches AI Security Layer Amid Rising Threats

Bank Security in the Age of AI You'd think banks, of all places, were impenetrable fortresses. But these days, they're more like digital targets. With AI-driven attacks becoming as common as morning coffee, Finzly's introducing Assure, an AI-powered security and assurance layer. It's about as timely as ever, given the 89% spike in AI-enabled attacks seen last year. When...

MemoryDriver Relaunches with Navigation Challenge

MemoryDriver's Relight: A Blazing New Course in Brain Health Look at this: Evon Medics is back with a bang, and they're handing us more than just another mind-numbing app update. On September 15, they're flipping the switch on MemoryDriver, their revamped brain-training gig, with a national 'Beat the Clock' Challenge. It’s up for grabs, totally free, and full of...

Flotek Faces Lawsuit: Investors Urged to Act Fast

Flotek's Current Storm: Gather Your Wits, Shareholders If you've staked your hard-earned cash into Flotek Industries, Inc. (FTK), it's high time to buckle up. Those court-blaring sirens aren’t a drill: we're talking class-action territory, people. The Law Offices of Howard G. Smith sound the alarm, calling on investors who’ve had their financial feathers singed to...

Little Sunshine's Opens New School in Peoria, AZ

Betting On Early Childhood Education Little Sunshine's Playhouse breaks ground on a fresh hub of learning in Peoria, Arizona, and this is no small playdate. It's the dawn of another preschool institution aiming to mold the early years of countless kiddos. The gears turning behind this development are impressive by themselves, but it's what it means for Peoria's families...